These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19644645)

  • 1. Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure.
    Gori T; Münzel T
    Clin Res Cardiol; 2009 Oct; 98(10):677-9. PubMed ID: 19644645
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
    Ruksin VV
    Sov Med; 1985; (2):54-6. PubMed ID: 3992326
    [No Abstract]   [Full Text] [Related]  

  • 3. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
    Münzel T
    MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
    [No Abstract]   [Full Text] [Related]  

  • 4. Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.
    Schofield PM; Brooks NH; Lawrence GP; Testa HJ; Ward C
    Br J Clin Pharmacol; 1991 Jan; 31(1):25-32. PubMed ID: 2015167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hydralazine on pressure-volume and stress-volume relations in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Smucker ML; Sanford CF; Lipscomb KM
    Am J Cardiol; 1985 Oct; 56(10):690-5. PubMed ID: 4050708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pre-existing cardiomyopathy during pregnancy.
    Gevaert S; De Pauw M; Tromp F; Ascoop AK; Roelens K; De Backer J
    Acta Cardiol; 2014 Apr; 69(2):193-6. PubMed ID: 24783472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
    Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M
    Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
    Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
    Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term vasodilator therapy of chronic refractory heart failure in patients with dilated cardiomyopathy].
    Moriuchi M; Saito S; Tamura Y; Kaseda N; Tsuji M; Tokutake E; Yumikura S; Hibiya K; Ozawa Y; Hatano M
    J Cardiogr Suppl; 1986; (9):77-85. PubMed ID: 3093596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained benefits or oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
    Shellock FG; Shah PK; Berman DS; Rubin SA; Singh BN; Swan HJ
    Clin Pharmacol Ther; 1980 Oct; 28(4):436-40. PubMed ID: 7408403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination vasodilator therapy for severe chronic congestive heart failure.
    Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
    Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic responses to vasodilator therapy in congestive heart failure.
    Ribner HS; Bresnahan D; Hsieh AM; Silverman R; Tommaso C; Coath A; Askenazi J
    Prog Cardiovasc Dis; 1982; 25(1):1-42. PubMed ID: 6287524
    [No Abstract]   [Full Text] [Related]  

  • 13. Ambulatory long-term vasodilator therapy for chronic refractory heart failure: hemodynamic evaluation and clinical response.
    Saito S; Ichikawa M; Ozawa Y; Yumikura S; Nagasawa M; Hibiya K; Tamura Y; Tomobe K; Hatano M
    Jpn Circ J; 1984 Apr; 48(4):350-6. PubMed ID: 6425526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained beneficial effects of oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
    Shah PK; Shellock FG; Berman DS; Rubin SA; Singh BN; Swan HJ
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2447-50. PubMed ID: 7422534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
    Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator therapy in chronic congestive heart failure.
    Schwartz AB; Chatterjee K
    Drugs; 1983 Aug; 26(2):148-73. PubMed ID: 6349967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current indications for vasodilator therapy for left ventricular failure.
    Franciosa JA
    Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.